Related Experiment Video
Updated: Sep 14, 2025
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Intake of fiber and micronutrients in patients with IBS
Bodil Roth1,2, Dalia Al-Shareef1, Bodil Ohlsson1,2
1Department of Clinical Sciences, Lund University, Malmö, Sweden.
Background And Aim:
Irritable bowel syndrome (IBS) is characterized by abdominal pain and altered bowel habits. Overweight and poor nutrient intake has been described in these patients. The aim of the study was to estimate nutrient intake in IBS, and to relate symptoms with nutrient intake and weight.
Methods:
Patients with IBS diagnosed according to Rome IV, without other severe diseases, completed a study questionnaire, IBS-severity scoring system (IBS-SSS), visual analog scale for IBS (VAS-IBS), and food diaries for 3 days. Mean intake of each nutrient per day was calculated. Recommended or adequate intake was a cut off for normal or low/high intake.
Results:
In total, 155 patients, 130 (83.9%) women, 42 (32-55) years old, weight 69.2 (63.0-82.9) kg, were included. Fiber intake was low in 91.0% of participants, whereas sodium intake was high in 71.6%. Intakes of vitamin A, vitamin D, riboflavin, vitamin B6, folate, vitamin B12, calcium, vitamin C, calcium, iron, magnesium, potassium, selenium, and zinc were reduced in ≥60% of participants. Half of the participants had a low intake of ≥11 of the 19 micronutrients measured. Most prominently, 85.8% had a low intake of vitamin D and 91.6% of selenium. 50.3% were overweight, and weight correlated with energy intake. Extraintestinal symptoms were associated with weight/BMI but not nutrients.
Conclusions:
Patients with IBS are often overweight with a low intake of fiber and several micronutrients but a high intake of sodium. Effects of micronutrient deficiency on gut microbiota, intestinal integrity, and immune system need to be further studied.
More Related Videos
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...